🇺🇸 FDA
Patent

US 7976834

Multi-arm polypeptide-poly(ethylene glycol) block copolymers as drug delivery vehicles

granted A61KA61K47/34A61K47/60

Quick answer

US patent 7976834 (Multi-arm polypeptide-poly(ethylene glycol) block copolymers as drug delivery vehicles) held by Nektar Therapeutics expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Jul 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K47/34, A61K47/60, A61K47/64, A61K9/5146